![Western Blot: DEPDC1A Antibody [26630002] - Samples: Lane 1, Marker [kDa]: 250, 130, 95, 72, 55, 36, 28, 17, 11 Lane 2, RT-4 Lane 3, U-251MG sp Lane 4, Human Plasma Lane 5, Liver Lane 6, Tonsil, Target weight [kDa]: 89, 61, 41, 31 (splice variants) Validation score: 2 Validation description: Supportive - Band of predicted size in kDa (+/-20%) with additional bands present.](http://www.bioprodhub.com/system/product_images/ab_products/5/sub_8/20760_DEPDC1A-Antibody-Western-Blot-26630002-img0002.jpg)
Western Blot: DEPDC1A Antibody [26630002] - Samples: Lane 1, Marker [kDa]: 250, 130, 95, 72, 55, 36, 28, 17, 11 Lane 2, RT-4 Lane 3, U-251MG sp Lane 4, Human Plasma Lane 5, Liver Lane 6, Tonsil, Target weight [kDa]: 89, 61, 41, 31 (splice variants) Validation score: 2 Validation description: Supportive - Band of predicted size in kDa (+/-20%) with additional bands present.
![Immunohistochemistry: DEPDC1A Antibody [26630002] - Most of the normal tissues displayed weak nuclear positivity. Moderate immunoreactivity was seen in trophoblastic cells, glandular cells of gastro-intestinal tract and thyroid gland, glomerular and tubular cells of kidney. Lymphoid tissues and myocytes were negative. A majority of cancers showed moderate nuclear positivity. Lymphomas were weakly stained. Hepatocellular carcinomas were negative. Image and statement courtesy of the Human Protein Atlas (HPA).](http://www.bioprodhub.com/system/product_images/ab_products/5/sub_8/20761_DEPDC1A-Antibody-Immunohistochemistry-26630002-img0001.jpg)
Immunohistochemistry: DEPDC1A Antibody [26630002] - Most of the normal tissues displayed weak nuclear positivity. Moderate immunoreactivity was seen in trophoblastic cells, glandular cells of gastro-intestinal tract and thyroid gland, glomerular and tubular cells of kidney. Lymphoid tissues and myocytes were negative. A majority of cancers showed moderate nuclear positivity. Lymphomas were weakly stained. Hepatocellular carcinomas were negative. Image and statement courtesy of the Human Protein Atlas (HPA).